Index by author
November 01, 1985; Volume 28,Issue 5
B
Berger, F G
- You have accessThymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.S H Berger, C H Jenh, L F Johnson and F G BergerMolecular Pharmacology November 1985, 28 (5) 461-467;
Berger, S H
- You have accessThymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.S H Berger, C H Jenh, L F Johnson and F G BergerMolecular Pharmacology November 1985, 28 (5) 461-467;
Brasier, R S
- You have accessAgonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.R R Neubig, R D Gantzos and R S BrasierMolecular Pharmacology November 1985, 28 (5) 475-486;
Burch, M
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
Bylund, D B
- You have accessAlpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.J T Turner, C Ray-Prenger and D B BylundMolecular Pharmacology November 1985, 28 (5) 422-430;
C
Culver, P
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
Cysyk, R L
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
D
Davies, H W
- You have accessImmunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.H Satoh, J R Gillette, H W Davies, R D Schulick and L R PohlMolecular Pharmacology November 1985, 28 (5) 468-474;
Drendel, W B
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
E
Ebetino, F H
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
Ehlert, F J
- You have accessThe relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.F J EhlertMolecular Pharmacology November 1985, 28 (5) 410-421;
F
Fenical, W
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
G
Gantzos, R D
- You have accessAgonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.R R Neubig, R D Gantzos and R S BrasierMolecular Pharmacology November 1985, 28 (5) 475-486;
George, S R
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
Gillette, J R
- You have accessImmunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.H Satoh, J R Gillette, H W Davies, R D Schulick and L R PohlMolecular Pharmacology November 1985, 28 (5) 468-474;
Glover, E
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
Grigoriadis, D
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
H
Henley, J M
- You have accessEpinephrine-stimulated maintained rubidium efflux from guinea pig hepatocytes may involve alpha 1- and alpha 2-adrenoceptors.J M HenleyMolecular Pharmacology November 1985, 28 (5) 431-435;
Hosey, M M
- You have accessAgonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.K K McMahon and M M HoseyMolecular Pharmacology November 1985, 28 (5) 400-409;
J
Jenh, C H
- You have accessThymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.S H Berger, C H Jenh, L F Johnson and F G BergerMolecular Pharmacology November 1985, 28 (5) 461-467;
Johnson, L F
- You have accessThymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.S H Berger, C H Jenh, L F Johnson and F G BergerMolecular Pharmacology November 1985, 28 (5) 461-467;
K
Karle, J M
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
Kende, A S
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
M
Malinowski, N
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
Malspeis, L
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
Marquez, V E
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
McMahon, K K
- You have accessAgonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.K K McMahon and M M HoseyMolecular Pharmacology November 1985, 28 (5) 400-409;
Moyer, J D
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
N
Neubig, R R
- You have accessAgonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.R R Neubig, R D Gantzos and R S BrasierMolecular Pharmacology November 1985, 28 (5) 475-486;
Neumeyer, J L
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
Nilsson, J L
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
P
Pohl, L R
- You have accessImmunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.H Satoh, J R Gillette, H W Davies, R D Schulick and L R PohlMolecular Pharmacology November 1985, 28 (5) 468-474;
Poland, A
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
Potenza, C
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
R
Ray-Prenger, C
- You have accessAlpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.J T Turner, C Ray-Prenger and D B BylundMolecular Pharmacology November 1985, 28 (5) 422-430;
S
Salam, M A
- You have accessInhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L CysykMolecular Pharmacology November 1985, 28 (5) 454-460;
Satoh, H
- You have accessImmunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.H Satoh, J R Gillette, H W Davies, R D Schulick and L R PohlMolecular Pharmacology November 1985, 28 (5) 468-474;
Schulick, R D
- You have accessImmunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.H Satoh, J R Gillette, H W Davies, R D Schulick and L R PohlMolecular Pharmacology November 1985, 28 (5) 468-474;
Seeman, P
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
Sundaralingam, M
- You have accessStructure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A PolandMolecular Pharmacology November 1985, 28 (5) 445-453;
Svensson, U
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
T
Taylor, P
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
Tedesco, J L
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
Turner, J T
- You have accessAlpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.J T Turner, C Ray-Prenger and D B BylundMolecular Pharmacology November 1985, 28 (5) 422-430;
W
Wasserman, L
- You have accessStructure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P TaylorMolecular Pharmacology November 1985, 28 (5) 436-444;
Watanabe, M
- You have accessDopamine D2 receptor binding sites for agonists. A tetrahedral model.P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L NeumeyerMolecular Pharmacology November 1985, 28 (5) 391-399;
In this issue

Advertisement